Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / KPTI - Karyopharm Therapeutics: Avoid In July 2019


KPTI - Karyopharm Therapeutics: Avoid In July 2019

Lately, Karyopharm Therapeutics (KPTI) has been one of the top trending tickers in the healthcare industry. The stock is up by 55.65% since July 1. Ironically, the stock is down by 5.98% in 2019 YTD. Still, this has not reduced the overall interest in the stock, from investors as well as analysts.

Karyopharm Therapeutics soared on July 3, after the company announced FDA accelerated approval for the first and only nuclear export inhibitor, XPOVIO (selinexor) in combination with dexamethasone for Penta relapsed or refractory MM (multiple myeloma) patients. On the same day, the

Read more ...

Stock Information

Company Name: Karyopharm Therapeutics Inc.
Stock Symbol: KPTI
Market: NASDAQ
Website: karyopharm.com

Menu

KPTI KPTI Quote KPTI Short KPTI News KPTI Articles KPTI Message Board
Get KPTI Alerts

News, Short Squeeze, Breakout and More Instantly...